The majority of respondents indicated that they definitely or probably would try parenteral nanoformulated antiretroviral therapy.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: